• Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer (mTNBC).
    • Keenan TE, Li T, Vallius T, Guerriero JL, Tayob N, Kochupurakkal BS, Davis J, Pastorello RG, Tahara RK, Anderson L, Conway J, He MX, Shannon E, Godin R, Sorger PK, D'Andrea AD, Overmoyer B, Winer EP, Mittendorf EA, Van Allen EM, Shapiro GI, Tolaney SM.
    • Clin Cancer Res. 2020 Nov 30. doi: 10.1158/1078-0432.CCR-20-3089. Epub ahead of print.